Austin, July 22, 2025 (GLOBE NEWSWIRE) -- Hematology Analyzers Market Size & Growth Analysis:
According to SNS Insider, the Hematology Analyzers Market size was valued at USD 5.51 billion in 2023 and is projected to reach USD 9.64 billion by 2032 and grow at a CAGR of 6.42% over the forecast period. The U.S. market, a key contributor to global revenue, was valued at USD 1.56 billion in 2023 and is expected to grow steadily to USD 2.57 billion by 2032.
Request Your Free Sample Copy of the Hematology Analyzers Market Report Today: https://www.snsinsider.com/sample-request/5665
The increasing incidence of blood-related disorders such as anemia, leukemia, and hemophilia, combined with a growing elderly population, is significantly boosting global demand. Technological advancements, such as automated and high-throughput hematology systems, have revolutionized the diagnostics space, ensuring timely results and improving patient outcomes.
The market is further propelled by the rising adoption of point-of-care testing, the growing number of diagnostic centers, and favorable government initiatives to improve healthcare infrastructure in emerging economies. In the United States, the emphasis on precision medicine, preventive diagnostics, and value-based healthcare is fueling sustained investment in hematology technologies.
Major Players Analysis Listed in this Report are:
- Abbott Laboratories (Architect Hematology Analyzer, Cell-Dyn Ruby)
- Sysmex Corporation (XS-500i Hematology Analyzer, XN-9000 Series)
- Siemens Healthineers (ADVIA 2120i Hematology System, Atellica COAG 360)
- Beckman Coulter, Inc. (DxH 800 Hematology Analyzer, UniCel DxC 600i Chemistry Analyzer)
- Horiba Medical (Pentra 60C, Pentra 80X)
- Mindray (BC-5300 Hematology Analyzer, BC-6800 Hematology Analyzer)
- Vermed, Inc. (Hematology Analyzer 9800, HumaCount 500)
- Diatron (A3 Hematology Analyzer, NEO Hematology Analyzer)
- Dendreon Corporation (PROVENGE, Provenge Immunotherapy)
- Roche Diagnostics (Cobas 6000, Cobas 8000)
- Schiller AG (Cardiovit AT-102 G2, Hematology Analyser 601)
- Tosoh Corporation (Hematology Analyzer G-900, G-600)
- Bio-Rad Laboratories (Eidias Hematology Analyzer, BioPlex 2200)
- Boule Diagnostics (Pentra 120, Penta 400)
- Alifax (ALIFAX Hematology Analyzer, ALIFAX iM8)
- STAGO (STA-R Evolution, STA Compact Max)
- Labcorp (Cobas 8000, Cobra Analysis)
- Becton Dickinson (BD FACSCalibur, BD Hematology Analyzer)
- Wako Pure Chemical Industries (Wako Hematology Analyzer, Wako Instruments)
- Cell-Dynamics (CELLAnalyzer 200, Hematology Analyzer H-4000)
Segment Analysis
By Product Type
The reagents segment held a share of a 48.23% in the hematology analyzers market in 2023, owing to its repeated end-use in routine blood tests and CBC analysis. Reagents are required on a daily basis in diagnostic routines, thus segment has high appeal for players in the market space. Quality reagents are the from which reliable results depend largely on in an assay procedure and are indispensable in a laboratory.
By Price Range
The mid-range hematology analyzers market was led by the mid-range hematology analyzers segment in 2023 and is projected to be the leading power throughout the forecast period from 2021 to 2026, 46.25% of the total Mid-range Hematology Analyzers market. These analyzers represent an optimal combination of price, quality, and performance for laboratories with higher testing volumes. They are very popular in expanding networks because of their scalability and automation compatibility.
By End-Use
Hospitals held the largest share of the hematology analyzers market in 2023, primarily due to high patient volumes and emergency diagnostics, which makes it the largest end-user of hematology analyzers and integrated lab systems. Volumes of hematology tests have been dominated by hospitals because of the fact that the units are heavily involved in both routine and emergency diagnostics.
For a Personalized Briefing with Our Industry Analysts, Connect Now: https://www.snsinsider.com/request-analyst/5665
Hematology Analyzers Market Segmentation
By Product Type
- Instruments
- Reagents
- Services
By Price Range
- Low-end Hematology Analyzers
- Mid-range Hematology Analyzers
- High-end Hematology Analyzers
By End-Use
- Hospitals
- Clinical Laboratories
- Research Institutes
- Other
Regional Analysis
The most significant market is North America, in 2023, it had 37.46% of the global total. The advantage of the region is the dominance of the major diagnostics manufacturers, a strong reimbursement system offered, and the presence of automated laboratory devices across the region.
The Asia Pacific is expected to be the fastest-growing market during the forecast period. Quick urbanization, growing level of awareness pertaining early disease detection and favorable government initiatives in countries such as India, China and Japan among others are few of the factors boosting the demand of the market in this region.
Recent Developments
- May 2024 – HORIBA, Ltd. (Japan), received U.S FDA 510(k) clearance for its Yumizen H2500 high-throughput hematology analyzer to improve the testing process in clinical labs.
- August 2023 – Abbott obtained FDA clearance for its Alinity h-series hematology system to provide CBC testing results with greater accuracy and make it a part of lab flow.
- May 2023 – Siemens Healthineers introduced Atellica HEMA 570 and HEMA 580 analyzers, which provide high-volume testing and streamline workflow in clinical laboratories.
Hematology Analyzers Market Report Scope
| Report Attributes | Details |
| Market Size in 2023 | US$ 5.51 billion |
| Market Size by 2032 | US$ 9.64 billion |
| CAGR | CAGR of 6.42% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Regional Analysis | North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, Poland, Turkey, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
| Key Growth Drivers |
|
Buy the Full Hematology Analyzers Market Report (Single-User License) Now: https://www.snsinsider.com/checkout/5665
Table of Contents – Major Key Points
1. Introduction
2. Executive Summary
3. Research Methodology
4. Market Dynamics Impact Analysis
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence (2023)
5.2 Prescription Trends (2023) by Region
5.3 Prescription Trends (2023), by Region
5.4 Healthcare Spending, by Region (Government, Commercial, Private, Out-of-Pocket), 2023
6. Competitive Landscape
7. Hematology Analyzers Market by Product Type
8. Hematology Analyzers Market by Price Range
9. Hematology Analyzers Market by End-Use
10. Regional Analysis
11. Company Profiles
12. Use Cases and Best Practices
13. Conclusion
Related Reports
Hematology Diagnostics Market Report
Bleeding Disorders Treatment Market Report
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
